Početna › Kronična limfocitna leukemija › Illinois › Chicago
Kliničke studije za Kronična limfocitna leukemija u gradu Chicago, IL
14 studija za Kronična limfocitna leukemija traži sudionike na lokacijama u gradu Chicago i okolici (unutar oko 30 milja). Otvorite studiju da biste vidjeli tko se može priključiti i kako kontaktirati tim studije.
Službeni tekst studije (engleski)
Tražite sudionike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL
U tijeku regrutacijaFaza 3
- Northwestern University, Chicago
- University of Illinois, Chicago
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
- Mount Sinai Hospital Medical Center, Chicago
- John H Stroger Jr Hospital of Cook County, Chicago
- University of Illinois, Chicago
- i još 1
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
U tijeku regrutacijaFaza 3
- Northwestern University, Chicago
- University of Chicago Comprehensive Cancer Center, Chicago
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)
U tijeku regrutacijaFaza 3
- Northwestern University, Chicago
A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia
U tijeku regrutacijaFaza 3
- Northwestern University, Chicago
A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
U tijeku regrutacijaFaza 3
- University of Chicago Medical Center, Chicago
A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies
U tijeku regrutacijaFaza 1
- The David and Etta Jonas Center for Cellular Therapy, Chicago
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
U tijeku regrutacijaFaza 1
- Northwestern University, Chicago
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
U tijeku regrutacijaFaza 1
- University of Chicago, Chicago
The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
U tijeku regrutacijaFaza 1/2
- University of Illinois at Chicago Cancer Center, Chicago
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
U tijeku regrutacijaFaza 1
- The University of Chicago Medical Center, Chicago
A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma
U tijeku regrutacijaFaza 4
- Northwestern University, Chicago
A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib
U tijeku regrutacijaFaza 4
- Northwestern University, Chicago
AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma
U tijeku regrutacijaFaza 1
- Northwestern Memorial Hospital, Chicago
Studije za Kronična limfocitna leukemija u drugim gradovima
- Boston, MA31 studija
- Columbus, OH28 studija
- Durham, NC27 studija
- Washington, DC22 studija
- Seattle, WA20 studija
- Rochester, MN19 studija
- New York City, NY18 studija
- Houston, TX17 studija
- Baldwin Park, CA16 studija
- Milwaukee, WI15 studija
- Cincinnati, OH14 studija
- Nashville, TN13 studija
Ostale studije u gradu Chicago
- Nemikrocelularni karcinom pluća61 studija
- Rak dojke58 studija
- Rak (sve vrste)51 studija
- Metastatski karcinom45 studija
- Rak prostate45 studija
- Debljina41 studija
- Rak pluća41 studija
- Rak jajnika36 studija
- Moždani udar34 studija
- Kolorektalni rak33 studija
- Srčano zatajenje31 studija
- Prekomjerna tjelesna masa28 studija
Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.